Clinical Trial Update: A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin. [Phase 1]

View source ↗

Summary

Phase 1 study to assess the effect of AZD0780 on the pharmacokinetics of rosuvastatin in individuals with dyslipidemia; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• AZD0780
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED